What We Have Learned: The Impact of Quality From a Clinical Trials Perspective
In this review article, we address the radiation oncology process improvements in clinical trials and review how these changes improve the quality for the next generation of trials. In recent years, we have progressed from a time of limited data acquisition to the present in which we have real-time influence of clinical trials quality. This enables immediate availability of the important elements, including staging, eligibility, response, and outcome for all trial investigators. Modern informatics platforms are well designed for future adaptive clinical trials. We review what will be needed in the informatics architecture of current and future clinical trials.
To access this article, please choose from the options below
Supported in part by NIH/NCI CA 29511 (Quality Assurance Review Center).
PII: S1053-4296(11)00095-6
doi:10.1016/j.semradonc.2011.09.004
© 2012 Elsevier Inc. All rights reserved.
